Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach
- PMID: 8432457
- PMCID: PMC1374105
- DOI: 10.1136/gut.34.1.80
Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach
Abstract
Carcinogenesis in the human colon is associated with a marked increase of urokinase type plasminogen activator and a decrease of tissue type plasminogen activator. This study was performed to determine the concentrations of urokinase type plasminogen activator and tissue type plasminogen activator in normal tissue and carcinomas along the upper part of the gastrointestinal tract. Activity and antigen levels of both activators were determined in homogenates of endoscopically obtained biopsies from normal and carcinomatous tissues. Although the concentrations of tissue type plasminogen activator and urokinase type plasminogen activator in normal squamous epithelium of the oesophagus were low compared with those in columnar epithelium from the stomach, the urokinase type plasminogen activator/tissue type plasminogen activator antigen ratio of the different locations showed hardly any difference. Significant but heterogeneous increases were found in urokinase type plasminogen activator concentrations of biopsy specimens originating from carcinomas of both epithelial cell types. A decrease in tissue type plasminogen activator concentrations, as found in human colon carcinomas, could only be shown in carcinomas of columnar epithelium origin but not in squamous cell carcinomas of the oesophagus. The increase of urokinase type plasminogen activator and urokinase type plasminogen activator/tissue type plasminogen activator antigen ratio and the decrease of tissue type plasminogen activator in the carcinomas did not show a significant correlation with known prognostic determinants as differentiation grade, TNM classification, intestinal metaplasia, inflammation, and ulceration. The heterogeneous increase of urokinase type plasminogen activator in oesophageal and stomach carcinomas, together with the recently described association of urokinase type plasminogen activator in tissue extracts of breast carcinomas with aggressiveness and prognosis, may be relevance to prognostic studies, may be of relevance to prognostic studies in oesophageal and gastric cancer.
Similar articles
-
Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.Br J Cancer. 1997;75(12):1793-801. doi: 10.1038/bjc.1997.306. Br J Cancer. 1997. PMID: 9192984 Free PMC article.
-
[Urokinase and tissue type plasminogen activators and their type-1 inhibitor (PAI-1) in gastric cancer].Vopr Onkol. 2003;49(2):165-9. Vopr Onkol. 2003. PMID: 12785198 Russian.
-
Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report.Cancer. 1988 Aug 1;62(3):531-3. doi: 10.1002/1097-0142(19880801)62:3<531::aid-cncr2820620315>3.0.co;2-b. Cancer. 1988. PMID: 3134120
-
Prognostic value of plasminogen activators and their inhibitors in colorectal cancer.Eur J Cancer. 1995 Jul-Aug;31A(7-8):1105-9. doi: 10.1016/0959-8049(95)00170-n. Eur J Cancer. 1995. PMID: 7577001 Review.
-
Plasminogen activator and cancer.Eur J Cancer Clin Oncol. 1984 May;20(5):577-82. doi: 10.1016/0277-5379(84)90001-4. Eur J Cancer Clin Oncol. 1984. PMID: 6376129 Review.
Cited by
-
Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patterns.Clin Exp Metastasis. 1998 Jan;16(1):62-73. doi: 10.1023/a:1006564002679. Clin Exp Metastasis. 1998. PMID: 9502078
-
Prognostic relevance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in gastric cancer.Virchows Arch. 1996 Feb;427(5):487-96. doi: 10.1007/BF00199509. Virchows Arch. 1996. PMID: 8624578
-
Reduced tissue type plasminogen activator activity of the gastroduodenal mucosa in peptic ulcer disease.Gut. 1993 Oct;34(10):1310-4. doi: 10.1136/gut.34.10.1310. Gut. 1993. PMID: 8244093 Free PMC article.
-
Invasion by esophageal cancer cells: functional contribution of the urokinase plasminogen activation system, and inhibition by antisense oligonucleotides to urokinase or urokinase receptor.Clin Exp Metastasis. 1999 Feb;17(1):77-85. doi: 10.1023/a:1026470417680. Clin Exp Metastasis. 1999. PMID: 10390151
-
Histamine and tissue fibrinolytic activity in duodenal ulcer disease.Dig Dis Sci. 1998 Jan;43(1):126-32. doi: 10.1023/a:1018888423882. Dig Dis Sci. 1998. PMID: 9508513
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical